Humira (drug)

May 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....

In its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott...

(Corrects to make clear competitor sought information on Intermune drug, paragraph 8) By Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and...

By Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies. The European Medicines...

April 26 (Reuters) - AbbVie Inc : * Says expects Q2 EPS, excluding items, of $0.78 to $0.80 * Says expects Q2 revenue will grow in low single digit percentage range * CEO says EU rejection of pfizer's xeljanz will not have dramatic short-term impact on...

April 26 (Reuters) - AbbVie Inc reported slightly better than expected quarterly results, fueled by surging sales of its Humira treatment for rheumatoid arthritis. The pharmaceuticals business, spun off by Abbott Laboratories at the beginning of the...

When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up." Two decades later, the senior vice president for...

Obese women may have an increased risk of developing rheumatoid arthritis — adding one more chronic illness to the list of ills brought on by extra pounds. Women with rheumatoid arthritis are already more prone to heart attacks than the general...

Eighteen year-old Lakeview High School Senior Alex King realized around her freshman year that she was a pretty darn good athlete. Three years later, she is a track all-star and has her sights set on grabbing a state title. For everyone who knew her...